To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SPG7TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
546 representative clones for gene SPG7 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI827568 brain, medulla .a 1 to 777 1 to 785   tiling clone,   783/785
(99 %)
30 diff
(96.2 %id)
TI_57171463   .a 1 to 777 67 to 851       783/851
(92 %)
31 diff
(96.4 %id)
TI_44171211   .a 268 to 1062 118 to 929       812/934
(86 %)
29 diff
(96.9 %id)
BI552556 brain, hippocampus .a 271 to 1062 1 to 809       809/814
(99 %)
31 diff
(96.2 %id)
DB461961 testis .a 272 to 749 1 to 478       478/478
(100 %)
3 diff
(99.4 %id)
DB477781 hippocampus .a 276 to 754 1 to 479       479/479
(100 %)
0 diff
(100 %id)
DB486523 hypothalamus .a 276 to 688 1 to 413       413/414
(99 %)
3 diff
(99.3 %id)
DB493539 hypothalamus .a 276 to 771 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
DB494185 hypothalamus .a 276 to 776 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
TI_44167797   .a 276 to 933 139 to 798       660/799
(82 %)
11 diff
(98.7 %id)
NM_003119.2   .a 276 to 3356 1 to 3081   RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3081/3081
(100 %)
0 diff
(100 %id)
BG719331 testis .a 277 to 1008 1 to 734       734/739
(99 %)
10 diff
(98.7 %id)
BG718946 testis .a 277 to 956 1 to 678       678/678
(100 %)
9 diff
(98.7 %id)
BI547116 brain, hippocampus .a 278 to 933 1 to 658       658/659
(99 %)
10 diff
(98.5 %id)
BC110530 PCR rescued clones .a 279 to 2937 2660 to 2     Submitted on the opposite strand 2659/2660
(99 %)
0 diff
(100 %id)
BC110531 PCR rescued clones .a 279 to 2937 2660 to 2     Submitted on the opposite strand 2659/2660
(99 %)
0 diff
(100 %id)
BI915083 brain .a 280 to 1075 1 to 796       796/797
(99 %)
5 diff
(99.4 %id)
TI_57239095   .a 280 to 1075 30 to 825       796/826
(96 %)
10 diff
(98.8 %id)
BC036104 Brain, hippocampus .a 282 to 3356 1 to 3075   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3075/3075
(100 %)
3 diff
(100.0 %id)
TI_44460035   .a 282 to 1020 24 to 765       742/766
(96 %)
15 diff
(98.1 %id)
AL042003 testis .a 284 to 803 1 to 521       521/521
(100 %)
4 diff
(99.3 %id)
AL553563 placenta, Placenta Cot 25-normalized .a 285 to 1367 1 to 1072       1072/1116
(96 %)
8 diff
(99.3 %id)
BX363782   .a 285 to 1279 1 to 991       991/1089
(91 %)
16 diff
(98.6 %id)
DB451002 testis .a 285 to 757 1 to 473       473/474
(99 %)
2 diff
(99.6 %id)
DB480510 hippocampus .a 285 to 795 1 to 510       510/511
(99 %)
5 diff
(99.1 %id)
Y16610   .a 285 to 3349 1 to 3065   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3065/3065
(100 %)
1 diff
(100.0 %id)
AL528117 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 286 to 767 6 to 493       488/706
(69 %)
15 diff
(97.9 %id)
BI518426 leukocyte .a 286 to 1020 1 to 738       738/739
(99 %)
13 diff
(98.3 %id)
BG470804 eye, retinoblastoma .a 287 to 990 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
BU553871 ovary, teratocarcinoma, cell line .a 289 to 1157 22 to 901       878/965
(90 %)
34 diff
(96.5 %id)
BQ636886 eye, retina .a 290 to 843 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BM903761 ovary (pool of 3) .a 290 to 1054 13 to 778       766/1048
(73 %)
8 diff
(99.3 %id)
BU846147 ovary, teratocarcinoma, cell line .a 290 to 1157 26 to 902       877/1008
(87 %)
24 diff
(97.7 %id)
BU930944 ovary, teratocarcinoma, cell line .a 290 to 970 25 to 704       680/927
(73 %)
16 diff
(98.3 %id)
CR983214 T-Lymphocytes .a 290 to 897 1 to 608       608/609
(99 %)
1 diff
(99.9 %id)
CR978950 T-Lymphocytes .a 290 to 834 1 to 545       545/545
(100 %)
0 diff
(100 %id)
AL044223 testis .a 292 to 659 1 to 368       368/374
(98 %)
1 diff
(99.8 %id)
BF984951 duodenal adenocarcinoma, cell line, small intestine .a 292 to 413 1 to 121       121/121
(100 %)
2 diff
(98.4 %id)
BU556603 ovary, teratocarcinoma, cell line .a 293 to 1157 1 to 868       868/915
(94 %)
10 diff
(99.0 %id)
BE903160 choriocarcinoma, placenta .a 295 to 1020 40 to 757   available from MGC,   718/758
(94 %)
13 diff
(98.3 %id)
BI769839 pooled lung and spleen .a 297 to 1004 1 to 700       700/700
(100 %)
9 diff
(98.8 %id)
TI_57179538   .a 297 to 1004 60 to 759       700/759
(92 %)
7 diff
(99.1 %id)
CN301620 embryonic stem cells, cell lines H1, H7, andH9 .a 298 to 967 1 to 671       671/671
(100 %)
1 diff
(99.9 %id)
CN301635 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 298 to 907 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
CN301628 embryonic stem cells, cell lines H1, H7, andH9 .a 299 to 979 1 to 682       682/682
(100 %)
2 diff
(99.8 %id)
BU173168 leiomyosarcoma, uterus .a 299 to 1054 23 to 790       768/843
(91 %)
21 diff
(97.6 %id)
BF313793 brain, neuroblastoma .a 300 to 722 1 to 424       424/426
(99 %)
8 diff
(98.2 %id)
BF347718 anaplastic oligodendroglioma with 1p/19qloss, brain .a 300 to 413 1 to 115       115/115
(100 %)
1 diff
(99.2 %id)
BF531047 anaplastic oligodendroglioma with 1p/19qloss, brain .a 300 to 904 1 to 602       602/602
(100 %)
6 diff
(99.1 %id)
BQ070473 brain, neuroblastoma, cell line .a 301 to 856 1 to 556       556/1136
(48 %)
3 diff
(99.8 %id)
BX458575 placenta .a 302 to 1289 1 to 986       986/1078
(91 %)
7 diff
(99.4 %id)
BI758245 brain .a 302 to 1053 1 to 750       750/763
(98 %)
14 diff
(98.2 %id)
TI_57220838   .a 302 to 1053 62 to 811       750/824
(91 %)
15 diff
(98.2 %id)
CN301632 embryonic stem cells, cell lines H1, H7, andH9 .a 304 to 663 1 to 360       360/360
(100 %)
1 diff
(99.8 %id)
BU849075 ovary, teratocarcinoma, cell line .a 305 to 1157 1 to 864       864/918
(94 %)
28 diff
(97.0 %id)
BU849558 ovary, teratocarcinoma, cell line .a 305 to 1053 1 to 750       750/921
(81 %)
6 diff
(99.4 %id)
TI_154186692   .a 305 to 1162 43 to 896       854/1002
(85 %)
11 diff
(99.0 %id)
CF125175 Chondrosarcoma Lung Metastasis cell lines, lung .a 306 to 1013 1 to 707       707/707
(100 %)
2 diff
(99.8 %id)
DA782706 brain .a 306 to 883 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
BM546591 brain, hippocampus .a 307 to 1054 20 to 768       749/1123
(66 %)
15 diff
(98.7 %id)
CR991158 T-Lymphocytes .a 313 to 891 1 to 579       579/581
(99 %)
1 diff
(99.9 %id)
BE253035 eye, retinoblastoma .a 315 to 897 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN301625 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 316 to 835 1 to 520       520/520
(100 %)
0 diff
(100 %id)
BE257847 eye, retinoblastoma .a 317 to 809 1 to 489       489/489
(100 %)
4 diff
(99.2 %id)
BU557835 adenocarcinoma, cell line, breast .a 323 to 879 1 to 559       559/1001
(55 %)
13 diff
(98.8 %id)
CA390302 eye, RPE/choroid .a 331 to 890 1 to 560       560/560
(100 %)
0 diff
(100 %id)
CN301624 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 351 to 912 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DA498049 brain .a 433 to 1007 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AW238884 lung, cell line .a 492 to 623 1 to 132       132/132
(100 %)
0 diff
(100 %id)
CN301630 embryonic stem cells, DMSO-treated H9 cellline .a 498 to 1131 1 to 634       634/634
(100 %)
4 diff
(99.4 %id)
BC035929 Duodenum, adenocarcinoma .a 512 to 3349 29 to 2866   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2838/2838
(100 %)
0 diff
(100 %id)
CO245418 Chondrosarcoma Lung Metastasis cell lines, lung .a 536 to 1141 41 to 642       602/798
(75 %)
22 diff
(97.3 %id)
CF780822 Pooled Chondrosarcoma Tumor cells .a 574 to 1283 8 to 716       709/923
(76 %)
7 diff
(99.3 %id)
DA985126 synovial membrane tissue from rheumatioidarthritis .a 606 to 1156 2 to 553   capped   552/552
(100 %)
5 diff
(99.1 %id)
CN301631 embryonic stem cells, cell lines H1, H7, andH9 .a 627 to 895 1 to 269       269/269
(100 %)
0 diff
(100 %id)
CO245344 Chondrosarcoma Lung Metastasis cell lines, lung .a 641 to 1367 1 to 721       721/819
(88 %)
16 diff
(98.1 %id)
CB145177 Liver .a 642 to 1131 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
CB147872 Liver .a 642 to 1134 1 to 493       493/493
(100 %)
3 diff
(99.4 %id)
BI160182 epithelioid carcinoma cell line, Pancreas .a 655 to 1157 1 to 507       507/661
(76 %)
8 diff
(98.8 %id)
BE934561 head_neck .a 668 to 1041 380 to 8       373/380
(98 %)
0 diff
(100 %id)
BE934589 head_neck .a 668 to 1074 402 to 1       402/402
(100 %)
7 diff
(98.3 %id)
BQ428544 leiomyosarcoma, uterus .a 694 to 1445 1 to 754       754/855
(88 %)
3 diff
(99.7 %id)
TI_1948154206   .a 695 to 1577 1007 to 131       877/1356
(64 %)
16 diff
(98.9 %id)
BE146254 head_neck .a 839 to 1330 19 to 508       490/522
(93 %)
9 diff
(98.3 %id)
BQ316295 colon .a 839 to 1417 13 to 591       579/591
(97 %)
16 diff
(97.3 %id)
BE737511 adenocarcinoma, Pancreas .a 846 to 1607 38 to 782       745/783
(95 %)
17 diff
(97.9 %id)
BU526650 epidermoid carcinoma, cell line, lung .a 863 to 1752 1 to 895       895/937
(95 %)
18 diff
(98.1 %id)
BE563626 adenocarcinoma, Pancreas .a 864 to 1617 1 to 753       753/932
(80 %)
21 diff
(97.8 %id)
BF858049 prostate_tumor .a 869 to 1231 371 to 9     Submitted on the opposite strand 363/371
(97 %)
1 diff
(99.8 %id)
BQ953948 epidermoid carcinoma, cell line, lung .a 872 to 1805 1 to 936       935/936
(99 %)
16 diff
(98.3 %id)
BP367353 thymus .a 931 to 1510 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
TI_44384929   .a 945 to 1758 54 to 872   AAA   819/1089
(75 %)
18 diff
(98.4 %id)
BI554138 anaplastic oligodendroglioma with 1p/19qloss, brain .a 946 to 1758 1 to 818       818/1118
(73 %)
18 diff
(98.4 %id)
CK000108 mixed .a 1034 to 1821 14 to 798       785/816
(96 %)
30 diff
(96.4 %id)
DR157478 human embryonic stem cells differentiated toan early endodermal cell type .a 1076 to 1815 21 to 760       740/760
(97 %)
6 diff
(99.3 %id)
BG253391 adenocarcinoma, cell line, Liver .a 1085 to 1849 1 to 769       769/992
(77 %)
42 diff
(95.8 %id)
DB165896 thyroid gland .a 1106 to 1849 2 to 748   capped   747/771
(96 %)
11 diff
(98.6 %id)
BM808283 ovary (pool of 3) .a 1108 to 1849 1 to 744       744/1108
(67 %)
10 diff
(99.1 %id)
AW411466 muscle, rhabdomyosarcoma .a 1152 to 1713 21 to 582     Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 562/582
(96 %)
6 diff
(99.0 %id)
DA259789 caudate nucleus .a 1156 to 1732 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BP298054   .a 1218 to 1800 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
DA150782 amygdala .a 1219 to 1786 2 to 572   capped   571/571
(100 %)
4 diff
(99.3 %id)
BG740007 skin .a 1231 to 2045 1 to 816       816/816
(100 %)
1 diff
(99.9 %id)
BM928613 hepatocellular carcinoma, cell line, Liver .a 1233 to 2074 1 to 848       848/1023
(82 %)
7 diff
(99.4 %id)
BQ645135 hepatocellular carcinoma, cell line, Liver .a 1233 to 2077 1 to 854       854/898
(95 %)
15 diff
(98.4 %id)
BQ652067 hepatocellular carcinoma, cell line, Liver .a 1233 to 2077 1 to 845       845/927
(91 %)
28 diff
(97.0 %id)
BF207003 brain, neuroblastoma .a 1291 to 2067 1 to 766       767/805
(95 %)
24 diff
(97.1 %id)
BU162750 melanotic melanoma, cell line, skin .a 1297 to 2150 1 to 862       862/864
(99 %)
14 diff
(98.4 %id)
BU838214 melanotic melanoma, cell line, skin .a 1297 to 2074 1 to 783       783/822
(95 %)
6 diff
(99.3 %id)
BU838769 melanotic melanoma, cell line, skin .a 1297 to 1960 1 to 663       663/952
(69 %)
14 diff
(98.6 %id)
BQ677492 melanotic melanoma, cell line, skin .a 1297 to 2067 1 to 779       779/909
(85 %)
22 diff
(97.6 %id)
BF345889 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1304 to 2172 12 to 867       858/968
(88 %)
57 diff
(94.2 %id)
BG830505 epithelioid carcinoma cell line, Pancreas .a 1318 to 1846 1 to 529       529/530
(99 %)
3 diff
(99.5 %id)
CN301629 embryonic stem cells, cell lines H1, H7, andH9 .a 1344 to 2074 10 to 741       732/741
(98 %)
7 diff
(99.1 %id)
BG171468 hypernephroma, cell line, Kidney .a 1434 to 2212 1 to 771       771/983
(78 %)
12 diff
(98.8 %id)
CD616349   .a 1439 to 1896 1 to 458       458/458
(100 %)
2 diff
(99.6 %id)
TI_57216774   .a 1474 to 2280 59 to 874       815/874
(93 %)
27 diff
(97.0 %id)
BX280172 brain .a 1475 to 1989 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BI756682 brain .a 1475 to 2280 1 to 815       814/815
(99 %)
21 diff
(97.5 %id)
BU538040 adenocarcinoma, cell line, breast .a 1505 to 2400 1 to 905       905/907
(99 %)
28 diff
(97.0 %id)
BU538347 adenocarcinoma, cell line, breast .a 1505 to 2395 1 to 901       901/959
(93 %)
17 diff
(98.3 %id)
BU558212 adenocarcinoma, cell line, breast .a 1505 to 2359 1 to 870       870/870
(100 %)
19 diff
(97.9 %id)
BU558231 adenocarcinoma, cell line, breast .a 1505 to 2382 1 to 888       888/896
(99 %)
17 diff
(98.2 %id)
BU956598 adenocarcinoma, cell line, breast .a 1505 to 2326 1 to 829       829/855
(96 %)
10 diff
(98.9 %id)
BG422052 Kidney, renal cell adenocarcinoma .a 1586 to 2378 1 to 794       791/912
(86 %)
25 diff
(97.3 %id)
BG424659 Kidney, renal cell adenocarcinoma .a 1586 to 2370 1 to 781       781/832
(93 %)
22 diff
(97.4 %id)
BE273364 Kidney, renal cell adenocarcinoma .a 1606 to 2233 1 to 627       627/711
(88 %)
15 diff
(97.9 %id)
BE273284 Kidney, renal cell adenocarcinoma .a 1606 to 2233 1 to 628       628/720
(87 %)
5 diff
(99.4 %id)
BM794127 Ascites, stomach .a 1626 to 2328 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
CN301623 embryonic stem cells, cell lines H1, H7, andH9 .a 1637 to 2058 22 to 443       422/443
(95 %)
6 diff
(98.7 %id)
CN301637 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1665 to 2233 1 to 570       570/577
(98 %)
3 diff
(99.5 %id)
BM791516 Ascites, stomach .a 1674 to 2317 1 to 644       644/644
(100 %)
0 diff
(100 %id)
BQ721023 sympathetic trunk .a 1675 to 2400 1 to 740       740/933
(79 %)
16 diff
(98.3 %id)
BU184794 hepatocellular carcinoma, cell line, Liver .a 1684 to 2550 1 to 878       878/1106
(79 %)
24 diff
(97.9 %id)
BU168090 hepatocellular carcinoma, cell line, Liver .a 1684 to 2736 1 to 1056       1056/1057
(99 %)
37 diff
(96.5 %id)
BQ648722 hepatocellular carcinoma, cell line, Liver .a 1684 to 2381 1 to 704       704/997
(70 %)
17 diff
(98.3 %id)
BQ650957 hepatocellular carcinoma, cell line, Liver .a 1684 to 2478 1 to 796       796/903
(88 %)
12 diff
(98.7 %id)
BU157353 ductal carcinoma, cell line, Pancreas .a 1698 to 2576 1 to 881       881/1045
(84 %)
7 diff
(99.4 %id)
BM917974 blood, natural killer cells, cell line .a 1726 to 2240 1 to 515       515/1170
(44 %)
8 diff
(99.4 %id)
BG896831 cartilage .a 1754 to 2062 85 to 393       309/325
(95 %)
6 diff
(98.2 %id)
CD616350   .a 1763 to 2315 558 to 3       556/558
(99 %)
10 diff
(98.3 %id)
BQ311466 breast_normal .a 1800 to 2142 1 to 341       341/341
(100 %)
1 diff
(99.8 %id)
BF111849 pooled .a 1822 to 2465 678 to 34       645/679
(94 %)
3 diff
(99.6 %id)
BG684795 B-cells, primary B-cells from tonsils (cell line) .a 1823 to 2549 1 to 737       732/737
(99 %)
12 diff
(98.4 %id)
CX788429 human embryonic stem cells .a 1877 to 2627 1 to 751       751/751
(100 %)
5 diff
(99.4 %id)
TI_57220767   .a 1891 to 2706 89 to 909       822/1024
(80 %)
28 diff
(97.3 %id)
BI758176 brain .a 1897 to 2706 1 to 815       816/930
(87 %)
23 diff
(97.6 %id)
AL120717 melanoma (MeWo cell line) .a 1957 to 2314 1 to 357       357/357
(100 %)
2 diff
(99.5 %id)
BE905429 epithelioid carcinoma, Pancreas .a 1969 to 2677 1 to 703       703/780
(90 %)
15 diff
(98.1 %id)
CR979911 T-Lymphocytes .a 1971 to 2690 1 to 721       721/724
(99 %)
2 diff
(99.8 %id)
BM051134 eye, normal pigmented retinal epithelium .a 2015 to 2639 1 to 629       629/629
(100 %)
8 diff
(98.8 %id)
CN301636 embryonic stem cells, DMSO-treated H9 cellline .a 2021 to 2586 1 to 566       566/566
(100 %)
5 diff
(99.2 %id)
BM047912 carcinoma, cell line, Prostate .a 2025 to 2759 1 to 740       740/902
(82 %)
18 diff
(98.1 %id)
BU542159 carcinoma, cell line, Prostate .a 2028 to 2890 1 to 868       868/880
(98 %)
15 diff
(98.3 %id)
BM704532 eye, optic nerve .a 2038 to 2569 1 to 532     Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 532/532
(100 %)
1 diff
(99.9 %id)
BQ923670 leiomyosarcoma, uterus .a 2059 to 2798 1 to 751       751/963
(77 %)
33 diff
(96.6 %id)
BF570486 Kidney, renal carcinoma (ascites) .a 2080 to 2598 84 to 593   fully sequenced,   510/593
(86 %)
12 diff
(98.0 %id)
TI_154197646   .a 2119 to 3079 1 to 961       961/1030
(93 %)
42 diff
(96.0 %id)
BQ232927 large cell carcinoma, lung .a 2138 to 3172 1 to 1048       1048/1088
(96 %)
41 diff
(96.3 %id)
BU179614 adenocarcinoma, Pancreas .a 2141 to 2971 1 to 835       835/935
(89 %)
23 diff
(97.6 %id)
AV751850 Pituitary .a 2144 to 2807 1 to 655       655/658
(99 %)
9 diff
(98.7 %id)
TI_154196014   .a 2145 to 2965 21 to 836       816/1033
(78 %)
63 diff
(94.0 %id)
BY995910   .a 2159 to 2832 10 to 683       674/683
(98 %)
7 diff
(99.0 %id)
AI061631 Liver .a 2160 to 2815 1 to 654       654/654
(100 %)
8 diff
(98.8 %id)
BU539152 adenocarcinoma, cell line, breast .a 2171 to 2858 1 to 699       699/1082
(64 %)
21 diff
(98.1 %id)
TI_57216572   .a 2186 to 2955 31 to 804       774/804
(96 %)
9 diff
(98.9 %id)
AJ709795 heart .a 2188 to 2650 498 to 36     Submitted on the opposite strand 463/498
(92 %)
0 diff
(100 %id)
BI756203 brain .a 2190 to 2955 1 to 769       769/769
(100 %)
3 diff
(99.7 %id)
R22768 whole brain .a 2209 to 2554 1 to 345       345/345
(100 %)
5 diff
(98.6 %id)
DB230748 trachea .a 2213 to 2717 2 to 506   capped   505/505
(100 %)
2 diff
(99.7 %id)
BM831875 stomach .a 2217 to 2620 1 to 404       404/404
(100 %)
0 diff
(100 %id)
AL576529 placenta, Placenta Cot 25-normalized .a 2257 to 3309 1039 to 1       1039/1039
(100 %)
24 diff
(97.7 %id)
AL563065 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2369 to 3296 932 to 1       932/932
(100 %)
5 diff
(99.5 %id)
BE394621 endometrium, adenocarcinoma cell line, uterus .a 2438 to 3156 1 to 706       706/779
(90 %)
23 diff
(97.1 %id)
CN301639 embryonic stem cells, DMSO-treated H9 cellline .a 2450 to 3274 1 to 825       825/825
(100 %)
0 diff
(100 %id)
BF570017 Kidney, renal carcinoma (ascites) .a 2568 to 3307 737 to 1   fully sequenced,   737/737
(100 %)
8 diff
(99.0 %id)
AW411467 muscle, rhabdomyosarcoma .a 2760 to 3349 628 to 38   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 591/591
(100 %)
3 diff
(99.5 %id)
BM671679 eye, optic nerve .a 2769 to 3348 598 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 580/580
(100 %)
0 diff
(100 %id)
DB381747 thyroid gland .a 2796 to 3348 554 to 1       554/554
(100 %)
14 diff
(97.5 %id)
R43503 whole brain .a 3187 to 3328 142 to 1       142/142
(100 %)
0 diff
(100 %id)
NM_199367.1   .b 1 to 2301 1 to 2301 exact RefSeq, AAA   2301/2301
(100 %)
0 diff
(100 %id)
AL543611 placenta, Placenta Cot 25-normalized .b 9 to 877 1 to 869   tiling clone,   869/869
(100 %)
0 diff
(100 %id)
CR609511 B cells (Ramos cell line) Cot 25-normalized .b 10 to 2243 1 to 2234 exact tiling clone,   2234/2234
(100 %)
0 diff
(100 %id)
BC007692 Placenta, choriocarcinoma .b 10 to 2301 1 to 2292 G56V E428* tiling clone, available from MGC, AAA   2292/2292
(100 %)
8 diff
(99.7 %id)
BQ068466 brain, neuroblastoma, cell line .b 631 to 1601 23 to 1009       987/1021
(96 %)
30 diff
(97.1 %id)
BX350625   .b 796 to 1670 874 to 1       874/878
(99 %)
5 diff
(99.5 %id)
CD107218 brain, Pituitary .b 889 to 1731 14 to 857       844/862
(97 %)
9 diff
(99.0 %id)
BE264626 lung, small cell carcinoma .b 1161 to 1673 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
CN301622 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1196 to 1389 1 to 195       195/195
(100 %)
1 diff
(99.5 %id)
AL570039 placenta, Placenta Cot 25-normalized .b 1345 to 2244 905 to 6       900/905
(99 %)
0 diff
(100 %id)
BC015411 Breast, mammary adenocarcinoma. .b 1348 to 2301 1 to 954   available from MGC, AAA   954/954
(100 %)
1 diff
(99.9 %id)
BG031429 breast, mammary adenocarcinoma, cell line .b 1349 to 2097 1 to 745   available from MGC,   745/747
(99 %)
12 diff
(98.4 %id)
BX363781   .b 1352 to 2243 890 to 1       890/891
(99 %)
20 diff
(97.8 %id)
TI_154108080   .b 1470 to 2301 932 to 104   AAA   829/952
(87 %)
8 diff
(99.2 %id)
R01379 liver and spleen .b 1518 to 1819 1 to 313       313/343
(91 %)
15 diff
(95.7 %id)
TI_227713113   .b 1519 to 2301 863 to 80   AAA   784/1022
(76 %)
8 diff
(99.3 %id)
CD367455 Alveolar Macrophage, lung .b 1585 to 2301 735 to 19   AAA   717/717
(100 %)
3 diff
(99.6 %id)
CA311098 Human Lung Epithelial cells, lung .b 1623 to 2301 697 to 19   AAA   679/679
(100 %)
1 diff
(99.9 %id)
CA447374 Chondrosarcoma, Left Pelvis .b 1623 to 2301 698 to 19   AAA   680/680
(100 %)
1 diff
(99.9 %id)
AW248711 lung, small cell carcinoma .b 1731 to 2293 577 to 14       564/577
(97 %)
0 diff
(100 %id)
BF356235 head_neck .b 1776 to 2015 257 to 17       241/257
(93 %)
0 diff
(100 %id)
BF476000 Prostate .b 1789 to 2301 513 to 1       513/513
(100 %)
0 diff
(100 %id)
AA781401   .b 1852 to 2302 458 to 8       451/458
(98 %)
0 diff
(100 %id)
R01265 liver and spleen .b 1894 to 2278 387 to 1       387/388
(99 %)
3 diff
(99.3 %id)
AI568876 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1908 to 2301 394 to 1       394/394
(100 %)
2 diff
(99.5 %id)
AA682242   .b 1929 to 2302 379 to 6       374/379
(98 %)
0 diff
(100 %id)
AA887723 colon, colon tumor RER+ .b 1983 to 2301 320 to 1       320/320
(100 %)
1 diff
(99.7 %id)
AW779214 pooled .b 2041 to 2301 276 to 13   AAA   264/264
(100 %)
2 diff
(99.3 %id)
TI_57163395   .c 1 to 730 23 to 754       732/759
(96 %)
23 diff
(97.0 %id)
BI837951 pooled pancreas and spleen .c 6 to 730 1 to 727   tiling clone,   727/732
(99 %)
25 diff
(96.6 %id)
C15128   .c 98 to 351 1 to 254   tiling clone,   254/254
(100 %)
1 diff
(99.7 %id)
CN301638 embryonic stem cells, cell lines H1, H7, andH9 .c 622 to 1277 1 to 656   tiling clone,   656/658
(99 %)
2 diff
(99.7 %id)
BX510233   .c 782 to 1377 1 to 594   tiling clone,   594/594
(100 %)
1 diff
(99.9 %id)
EC561500 Prostate .c 878 to 979 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
AA377135 small intestine .d 1 to 194 1 to 195   tiling clone,   195/195
(100 %)
3 diff
(98.5 %id)
BF996997 placenta_normal .d 7 to 183 178 to 2   tiling clone,   177/188
(94 %)
0 diff
(100 %id)
GD143785   .d 130 to 225 102 to 7     Submitted on the opposite strand 96/104
(92 %)
0 diff
(100 %id)
GD143795   .d 130 to 225 102 to 7   tiling clone, Submitted on the opposite strand 96/107
(89 %)
0 diff
(100 %id)
D63198   .d 188 to 499 1 to 311   tiling clone,   311/311
(100 %)
1 diff
(99.7 %id)
BI114770 muscle, rhabdomyosarcoma .d 357 to 1028 1 to 680   tiling clone,   678/850
(79 %)
15 diff
(98.3 %id)
CN413420 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 1 to 644 1 to 643   tiling clone,   643/643
(100 %)
2 diff
(99.7 %id)
AA741158 germinal center B cell .e 224 to 579 1 to 356     Submitted on the opposite strand 356/356
(100 %)
4 diff
(98.9 %id)
DB045626 testis .e 266 to 812 2 to 548   tiling clone, capped   547/547
(100 %)
0 diff
(100 %id)
BF801974 colon_ins .e 314 to 628 315 to 1     Submitted on the opposite strand 315/315
(100 %)
1 diff
(99.7 %id)
BF353421 head_neck .e 431 to 634 205 to 3       203/208
(97 %)
0 diff
(100 %id)
BG955359 colon .e 673 to 1284 610 to 3       608/612
(99 %)
11 diff
(98.3 %id)
BG956310 colon .e 673 to 1284 610 to 3       608/612
(99 %)
11 diff
(98.3 %id)
BE540922 cervix .e 739 to 1332 1 to 601   tiling clone,   601/905
(66 %)
15 diff
(98.4 %id)
CN301621 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 823 to 1529 1 to 707   tiling clone,   707/707
(100 %)
0 diff
(100 %id)
BQ359325 head_normal .e 1051 to 1378 8 to 332       325/339
(95 %)
16 diff
(95.3 %id)
DR762028 embryonic stem .e 1283 to 2030 1 to 747   tiling clone,   747/747
(100 %)
7 diff
(99.1 %id)
CX760232 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 1524 to 2307 1 to 775   tiling clone, Submitted on the opposite strand 775/775
(100 %)
15 diff
(98.1 %id)
AK094627 amygdala .f 1 to 2041 2 to 2045 R105Q tiling clone, available from FLJ,   2045/2048
(99 %)
10 diff
(99.6 %id)
DA157094 amygdala .f 1 to 583 2 to 583   capped   582/582
(100 %)
6 diff
(99.0 %id)
CV356859 kidney_tumor .f 57 to 463 31 to 442   tiling clone,   412/442
(93 %)
6 diff
(98.7 %id)
DB151721 thymus .f 172 to 741 2 to 571   tiling clone, capped   570/570
(100 %)
4 diff
(99.3 %id)
DB301973 amygdala .f 1537 to 2041 513 to 4   tiling clone,   510/513
(99 %)
0 diff
(100 %id)
BQ349819 head_neck .g 1 to 450 463 to 9   tiling clone,   455/463
(98 %)
0 diff
(100 %id)
CV328995 nervous_tumor .g 51 to 470 436 to 17     Submitted on the opposite strand 420/436
(96 %)
1 diff
(99.8 %id)
BG773692 choriocarcinoma, placenta .g 179 to 943 1 to 738   tiling clone,   604/856
(70 %)
15 diff
(98.3 %id)
BF879799 lung_tumor .g 492 to 693 212 to 3     Submitted on the opposite strand 210/212
(99 %)
0 diff
(100 %id)
BM824329 Ascites, stomach .g 525 to 1182 1 to 658   tiling clone,   658/658
(100 %)
0 diff
(100 %id)
AF034795   .g 608 to 2999 1 to 2407 E6R A7P V8* tiling clone,   2407/2415
(99 %)
40 diff
(98.4 %id)
CR985963 T-Lymphocytes .g 1133 to 2075 1 to 947   tiling clone,   947/950
(99 %)
9 diff
(99.1 %id)
AW897871 nervous_normal .g 1311 to 1532 221 to 2       220/232
(94 %)
0 diff
(100 %id)
AA236804 germinal center B cell .g 2105 to 2602 1 to 495       495/495
(100 %)
7 diff
(98.6 %id)
BQ439391 embryonal carcinoma, cell line, testis .g 2116 to 2995 1 to 882       882/882
(100 %)
10 diff
(98.9 %id)
TI_149311623   .g 2118 to 2991 957 to 92   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 866/960
(90 %)
19 diff
(98.1 %id)
BE092408 breast .g 2119 to 2564 455 to 10     Submitted on the opposite strand 446/457
(97 %)
0 diff
(100 %id)
BE940101 uterus_tumor .g 2119 to 2674 10 to 563       554/565
(98 %)
7 diff
(98.8 %id)
CF128278 Chondrosarcoma Lung Metastasis cell lines, lung .g 2119 to 2841 10 to 731       722/731
(98 %)
6 diff
(99.2 %id)
TI_154113125   .g 2119 to 2991 954 to 87   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 868/965
(89 %)
26 diff
(97.4 %id)
TI_154194131   .g 2120 to 2999 60 to 939       880/1037
(84 %)
6 diff
(99.5 %id)
TI_159723167   .g 2126 to 2991 921 to 61   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 861/1008
(85 %)
13 diff
(98.8 %id)
BI523296 brain .g 2159 to 2917 774 to 10       765/774
(98 %)
0 diff
(100 %id)
TI_44185301   .g 2159 to 2917 774 to 10       765/774
(98 %)
0 diff
(100 %id)
BE076543 breast .g 2164 to 2569 414 to 6     Submitted on the opposite strand 409/414
(98 %)
0 diff
(100 %id)
TI_149278946   .g 2170 to 2991 897 to 77   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 821/1100
(74 %)
13 diff
(98.9 %id)
TI_149308953   .g 2171 to 2998 910 to 86   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 825/967
(85 %)
9 diff
(99.1 %id)
TI_149311696   .g 2171 to 2998 902 to 88   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 815/948
(85 %)
9 diff
(99.1 %id)
TI_149300073   .g 2174 to 2991 888 to 77   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 812/927
(87 %)
8 diff
(99.2 %id)
BE713069 head_neck .g 2190 to 2491 1 to 302       302/302
(100 %)
3 diff
(99.1 %id)
BE713089 head_neck .g 2190 to 2569 1 to 380       380/380
(100 %)
2 diff
(99.5 %id)
CD616347   .g 2205 to 2860 673 to 19       655/681
(96 %)
0 diff
(100 %id)
CD616348   .g 2205 to 2857 8 to 657       650/676
(96 %)
8 diff
(98.9 %id)
TI_149308082   .g 2222 to 2997 860 to 89   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 772/958
(80 %)
11 diff
(98.9 %id)
DN990496 brain, whole brain .g 2224 to 2843 1 to 618       618/618
(100 %)
7 diff
(98.9 %id)
BM976141 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 2228 to 2991 782 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 764/764
(100 %)
0 diff
(100 %id)
BM826997 Ascites, stomach .g 2232 to 2578 1 to 347       347/347
(100 %)
0 diff
(100 %id)
BC052587 Salivary gland, epidermoid carcinoma .g 2243 to 3000 1 to 758   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 758/758
(100 %)
1 diff
(99.9 %id)
TI_154130759   .g 2243 to 2991 828 to 93   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 736/906
(81 %)
10 diff
(98.9 %id)
BQ673656 epidermoid carcinoma, cell line, salivary gland .g 2244 to 2955 1 to 714   available from MGC,   714/944
(75 %)
19 diff
(98.0 %id)
CA944945 Human Lung Epithelial cells, lung .g 2246 to 2991 764 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 746/746
(100 %)
1 diff
(99.9 %id)
BU616714 Bone, Subchondral Bone .g 2249 to 2991 761 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 743/743
(100 %)
0 diff
(100 %id)
AA147448 uterus .g 2256 to 2579 7 to 339   fully sequenced,   333/339
(98 %)
17 diff
(95.0 %id)
BQ183364 Knee, Osteoarthritic Cartilage .g 2261 to 2991 748 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 730/730
(100 %)
6 diff
(99.2 %id)
BF081589 amnion_normal .g 2262 to 2691 432 to 3       430/432
(99 %)
0 diff
(100 %id)
CA442356 Fibrosarcoma .g 2262 to 2998 755 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 737/737
(100 %)
0 diff
(100 %id)
AA101649 uterus .g 2263 to 2669 1 to 409   fully sequenced,   409/409
(100 %)
8 diff
(98.1 %id)
TI_149296785   .g 2266 to 2991 830 to 109   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 722/753
(95 %)
20 diff
(97.4 %id)
AW845398 colon .g 2272 to 2681 1 to 410       410/410
(100 %)
3 diff
(99.3 %id)
BU687395 lung .g 2275 to 2998 742 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 724/724
(100 %)
2 diff
(99.8 %id)
BM977423 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 2275 to 2991 735 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 717/717
(100 %)
0 diff
(100 %id)
TI_153964277   .g 2276 to 2850 95 to 680       586/1332
(43 %)
16 diff
(98.8 %id)
BF761063 colon_est .g 2299 to 2675 44 to 419       376/419
(89 %)
6 diff
(98.6 %id)
BM677528 eye, fetal eye .g 2304 to 2991 703 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 685/685
(100 %)
3 diff
(99.6 %id)
BM977478 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 2307 to 2998 710 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 692/692
(100 %)
0 diff
(100 %id)
CN301633 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 2309 to 2805 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
CA425265 Bone, Subchondral Bone .g 2309 to 2997 707 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 689/689
(100 %)
7 diff
(99.0 %id)
BQ774146 Bone, Human Chondrosarcoma Cell Line .g 2311 to 2998 705 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 687/687
(100 %)
7 diff
(99.0 %id)
CA429144 Cell Line, Chondrosarcoma .g 2316 to 2998 700 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 682/682
(100 %)
7 diff
(99.0 %id)
BQ021150 lung, Metastatic Chondrosarcoma .g 2318 to 2991 692 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 674/677
(99 %)
1 diff
(99.9 %id)
BP430755   .g 2322 to 2758 1 to 437       437/437
(100 %)
4 diff
(99.1 %id)
BF880544 lung_tumor .g 2339 to 2704 374 to 13     Submitted on the opposite strand 362/379
(95 %)
0 diff
(100 %id)
BQ774135 Bone, Human Chondrosarcoma Cell Line .g 2341 to 2998 677 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 659/659
(100 %)
5 diff
(99.3 %id)
BU686962 lung, Primary Lung Epithelial Cells .g 2344 to 2997 672 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
BI054655 placenta_normal .g 2345 to 2494 149 to 2       148/149
(99 %)
0 diff
(100 %id)
BU678654 lung, Primary Lung Epithelial Cells .g 2345 to 2991 664 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 646/646
(100 %)
1 diff
(99.9 %id)
BP430988   .g 2357 to 2825 1 to 469       469/469
(100 %)
3 diff
(99.4 %id)
AW351658 colon .g 2359 to 2620 262 to 1       262/262
(100 %)
2 diff
(99.3 %id)
AW375274 colon .g 2359 to 2693 335 to 1       335/335
(100 %)
4 diff
(98.9 %id)
AV655869 corresponding non cancerous liver tissue .g 2360 to 2999 1 to 641     Submitted on the opposite strand 641/648
(98 %)
7 diff
(99.0 %id)
CA448717 Chondrosarcoma, Left Pelvis .g 2365 to 2991 645 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 627/627
(100 %)
1 diff
(99.9 %id)
BU616486 Bone, Subchondral Bone .g 2395 to 2998 621 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 603/603
(100 %)
1 diff
(99.9 %id)
BF892541 marrow .g 2396 to 2933 540 to 4     Submitted on the opposite strand 537/546
(98 %)
0 diff
(100 %id)
BF934814 nervous_tumor .g 2425 to 2829 407 to 3     Submitted on the opposite strand 405/407
(99 %)
0 diff
(100 %id)
AI813559 lymph node, lymphoma, follicular mixed small and largecell .g 2430 to 2991 562 to 1       562/562
(100 %)
3 diff
(99.5 %id)
BM969295 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 2432 to 2991 578 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 560/560
(100 %)
0 diff
(100 %id)
AW135053   .g 2441 to 2998 575 to 18   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 558/558
(100 %)
0 diff
(100 %id)
AI026650   .g 2445 to 2995 556 to 2       555/556
(99 %)
0 diff
(100 %id)
AI084073 B-cell, chronic lymphotic leukemia .g 2445 to 2992 548 to 1       548/548
(100 %)
0 diff
(100 %id)
AW515311 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .g 2445 to 2995 552 to 2       551/552
(99 %)
0 diff
(100 %id)
W65330 heart .g 2446 to 2737 1 to 289   fully sequenced,   289/289
(100 %)
10 diff
(96.6 %id)
AI341670   .g 2458 to 2995 542 to 5       538/542
(99 %)
0 diff
(100 %id)
AA535133 colon .g 2459 to 2991 533 to 1       533/533
(100 %)
6 diff
(98.9 %id)
BU615795 Bone, Subchondral Bone .g 2482 to 2991 528 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 510/519
(98 %)
0 diff
(100 %id)
AA040830 uterus .g 2490 to 2943 1 to 469       469/474
(98 %)
23 diff
(95.2 %id)
AI498507 anaplastic oligodendroglioma, brain .g 2490 to 2997 512 to 5       508/512
(99 %)
0 diff
(100 %id)
DB542027 hippocampus .g 2491 to 2998 1 to 508     Submitted on the opposite strand 508/508
(100 %)
0 diff
(100 %id)
BE042719 colon, moderately-differentiated adenocarcinoma .g 2492 to 2994 503 to 1       503/503
(100 %)
0 diff
(100 %id)
AW168241 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 2496 to 2995 506 to 3       504/506
(99 %)
0 diff
(100 %id)
BE464807 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .g 2498 to 2997 510 to 7       504/510
(98 %)
0 diff
(100 %id)
AI141503 heart .g 2500 to 2992 493 to 1       493/493
(100 %)
0 diff
(100 %id)
BF064213 pooled .g 2500 to 2991 506 to 11   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 496/496
(100 %)
2 diff
(99.6 %id)
BM692843 eye, Retina Foveal and Macular .g 2502 to 2984 1 to 483       483/483
(100 %)
0 diff
(100 %id)
AI261786 Kidney .g 2508 to 2992 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AI401316 brain, glioblastoma (pooled) .g 2509 to 2997 499 to 7       493/499
(98 %)
0 diff
(100 %id)
AI089570 uterus .g 2515 to 2991 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AI697222 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 2517 to 2992 476 to 1       476/476
(100 %)
0 diff
(100 %id)
DB527381 testis .g 2518 to 2989 1 to 472     Submitted on the opposite strand 472/474
(99 %)
1 diff
(99.8 %id)
DB551315 hippocampus .g 2518 to 2998 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AI125745   .g 2520 to 2990 499 to 25   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 475/475
(100 %)
2 diff
(99.6 %id)
BF853688 lung_normal .g 2524 to 2834 321 to 7     Submitted on the opposite strand 315/321
(98 %)
0 diff
(100 %id)
CR742990 germinal center B cell .g 2525 to 2991 1 to 471   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 471/471
(100 %)
2 diff
(99.6 %id)
AW297406   .g 2527 to 2827 15 to 315     Submitted on the opposite strand 301/315
(95 %)
9 diff
(97.2 %id)
AI862597 B-cell, chronic lymphotic leukemia .g 2529 to 2991 478 to 13   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 466/466
(100 %)
5 diff
(99.0 %id)
DB549266 hippocampus .g 2531 to 2991 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
AA504559 germinal center B cell .g 2533 to 2605 1 to 72   fully sequenced, Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 72/72
(100 %)
2 diff
(97.3 %id)
DB522315 testis .g 2534 to 2998 1 to 465     Submitted on the opposite strand 465/465
(100 %)
2 diff
(99.6 %id)
DB536121 hippocampus .g 2534 to 2991 1 to 457     Submitted on the opposite strand 457/457
(100 %)
8 diff
(98.3 %id)
DW418697 Liver .g 2537 to 2934 17 to 418       402/418
(96 %)
6 diff
(98.6 %id)
DB555525 hypothalamus .g 2538 to 2997 1 to 460     Submitted on the opposite strand 460/460
(100 %)
6 diff
(98.7 %id)
DB516494 testis .g 2546 to 2995 1 to 450     Submitted on the opposite strand 450/452
(99 %)
1 diff
(99.8 %id)
BF056197 pooled .g 2546 to 2999 462 to 5       458/462
(99 %)
0 diff
(100 %id)
BM740146 stomach .g 2546 to 2991 1 to 445   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 445/445
(100 %)
1 diff
(99.8 %id)
BM793419 stomach .g 2546 to 2991 1 to 446   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
BM832792 stomach .g 2546 to 2991 1 to 446   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
DB565225 hypothalamus .g 2549 to 2997 1 to 449     Submitted on the opposite strand 449/449
(100 %)
1 diff
(99.8 %id)
AA156458 uterus .g 2549 to 2992 445 to 1   fully sequenced,   445/445
(100 %)
6 diff
(98.7 %id)
AA570090 colon .g 2549 to 2991 442 to 1       442/442
(100 %)
5 diff
(98.9 %id)
AA639601 colon, colon tumor RER+ .g 2549 to 2991 471 to 28   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 444/444
(100 %)
7 diff
(98.5 %id)
AA814232 2 pooled tumors (clear cell type), Kidney .g 2549 to 2997 452 to 5       448/452
(99 %)
0 diff
(100 %id)
AA921327 Spleen .g 2549 to 2813 265 to 2       264/265
(99 %)
0 diff
(100 %id)
AA886369 Kidney .g 2549 to 2998 449 to 1       449/449
(100 %)
4 diff
(99.2 %id)
AA926925 pooled germ cell tumors .g 2549 to 2998 449 to 1       449/449
(100 %)
7 diff
(98.5 %id)
AA927758 pooled germ cell tumors .g 2549 to 3000 451 to 1       451/451
(100 %)
10 diff
(97.8 %id)
AA948175 pooled germ cell tumors .g 2549 to 2991 442 to 1       442/442
(100 %)
6 diff
(98.7 %id)
AI018442   .g 2549 to 2999 453 to 4       450/453
(99 %)
0 diff
(100 %id)
AI129089 senescent fibroblast .g 2549 to 2995 443 to 2       442/443
(99 %)
0 diff
(100 %id)
AI186532 heart .g 2549 to 2998 454 to 1       454/454
(100 %)
2 diff
(99.6 %id)
AI193707 lung .g 2549 to 2998 456 to 1       456/456
(100 %)
11 diff
(97.6 %id)
AI244394 Kidney .g 2549 to 2991 447 to 1       447/447
(100 %)
8 diff
(98.3 %id)
AI373704 uterus .g 2549 to 2991 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI625629 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .g 2549 to 2998 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
AI672851 colon, colonic mucosa from 3 patients with Crohn'sdisease .g 2549 to 2999 453 to 3       451/453
(99 %)
0 diff
(100 %id)
AI886817 lymph node, lymphoma, follicular mixed small and largecell .g 2549 to 2991 444 to 1       444/444
(100 %)
22 diff
(95.1 %id)
AI986209 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 2549 to 2991 467 to 24   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 444/444
(100 %)
3 diff
(99.4 %id)
AW337255 adenocarcinoma, Pancreas .g 2549 to 2991 462 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 447/447
(100 %)
3 diff
(99.4 %id)
BF589756 sciatic nerve .g 2549 to 2999 459 to 9       451/459
(98 %)
0 diff
(100 %id)
BG273014 nasopharynx, normal epithelium .g 2549 to 2997 463 to 15       449/463
(96 %)
0 diff
(100 %id)
DB560427 hypothalamus .g 2552 to 2991 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
AI475913 B-cell, chronic lymphotic leukemia .g 2552 to 2999 453 to 2       452/453
(99 %)
0 diff
(100 %id)
AI678614 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .g 2552 to 3000 448 to 1       448/451
(99 %)
15 diff
(96.7 %id)
AI970639 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .g 2554 to 2999 447 to 3       445/452
(98 %)
0 diff
(100 %id)
DB564614 hypothalamus .g 2555 to 2997 1 to 443     Submitted on the opposite strand 443/443
(100 %)
1 diff
(99.8 %id)
AA719931 heart .g 2557 to 2999 454 to 8       447/454
(98 %)
0 diff
(100 %id)
DB546387 hippocampus .g 2558 to 2995 1 to 438     Submitted on the opposite strand 438/440
(99 %)
3 diff
(99.4 %id)
AA040743 uterus .g 2560 to 2991 441 to 1       441/447
(98 %)
13 diff
(97.1 %id)
DB515473 testis .g 2563 to 2990 1 to 431     Submitted on the opposite strand 431/432
(99 %)
23 diff
(94.7 %id)
DB532841 hippocampus .g 2564 to 2997 1 to 434     Submitted on the opposite strand 434/434
(100 %)
12 diff
(97.3 %id)
BF475769 sciatic nerve .g 2564 to 2997 438 to 3       436/438
(99 %)
0 diff
(100 %id)
AW006639 colon .g 2565 to 2998 453 to 20   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 434/434
(100 %)
0 diff
(100 %id)
W60734 heart .g 2569 to 2992 1 to 434   fully sequenced,   434/434
(100 %)
23 diff
(94.8 %id)
DB560052 hypothalamus .g 2572 to 2997 1 to 428     Submitted on the opposite strand 428/428
(100 %)
15 diff
(96.5 %id)
AA504482 germinal center B cell .g 2575 to 2991 433 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 420/420
(100 %)
3 diff
(99.3 %id)
S54769   .g 2577 to 2991 1 to 415   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 415/415
(100 %)
0 diff
(100 %id)
BF342214 brain, glioblastoma with EGFR amplification .g 2579 to 2911 1 to 331       331/567
(58 %)
3 diff
(99.5 %id)
BQ029745 lung, Metastatic Chondrosarcoma .g 2580 to 2998 437 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 419/419
(100 %)
0 diff
(100 %id)
BM829655 stomach .g 2581 to 2991 1 to 412   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 412/413
(99 %)
25 diff
(94.0 %id)
T50167 ovary .g 2582 to 2981 1 to 400   fully sequenced,   400/400
(100 %)
13 diff
(96.8 %id)
AW020174 cochlea, ear .g 2582 to 2993 1 to 411       411/411
(100 %)
5 diff
(98.8 %id)
AI174433   .g 2585 to 2991 421 to 18   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 404/404
(100 %)
11 diff
(97.3 %id)
AI589566 anaplastic oligodendroglioma, brain .g 2598 to 2993 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AW071858 anaplastic oligodendroglioma, brain .g 2598 to 2993 396 to 1       396/396
(100 %)
0 diff
(100 %id)
F00723 leg muscle, skeletal muscle .g 2600 to 2919 1 to 323       323/326
(99 %)
13 diff
(96.1 %id)
AI804672 Prostate .g 2603 to 2995 399 to 7       393/399
(98 %)
0 diff
(100 %id)
AI804693 Prostate .g 2603 to 2995 399 to 7       393/399
(98 %)
0 diff
(100 %id)
AI686697 Prostate .g 2603 to 2991 407 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 389/389
(100 %)
0 diff
(100 %id)
BM794670 Ascites, stomach .g 2607 to 2991 1 to 385   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
W60877 heart .g 2609 to 2992 393 to 1   fully sequenced,   393/393
(100 %)
7 diff
(98.3 %id)
BQ030116 lung, Metastatic Chondrosarcoma .g 2611 to 2998 406 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 388/388
(100 %)
0 diff
(100 %id)
AA507575 breast .g 2616 to 2999 389 to 2       388/389
(99 %)
0 diff
(100 %id)
F30813 pectoral muscle (after mastectomy) .g 2617 to 2995 1 to 382       382/395
(96 %)
4 diff
(99.0 %id)
R60791 whole brain .g 2618 to 2999 399 to 8       392/409
(95 %)
0 diff
(100 %id)
AI700280 colon .g 2620 to 2993 378 to 1       378/378
(100 %)
6 diff
(98.5 %id)
AA828143 ovary .g 2628 to 2995 372 to 5       368/372
(98 %)
0 diff
(100 %id)
DW444526 Liver .g 2632 to 2845 10 to 226       217/226
(96 %)
9 diff
(96.1 %id)
BM664632 eye, human retina .g 2636 to 2991 374 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 356/356
(100 %)
0 diff
(100 %id)
AI302927 2 pooled tumors (clear cell type), Kidney .g 2637 to 2997 370 to 4       367/370
(99 %)
0 diff
(100 %id)
AI471402 colon, moderately-differentiated adenocarcinoma .g 2637 to 2995 358 to 2       357/362
(98 %)
0 diff
(100 %id)
R50368 breast .g 2638 to 2991 355 to 1       355/355
(100 %)
4 diff
(98.9 %id)
AA101650 uterus .g 2639 to 2992 358 to 1   fully sequenced,   358/358
(100 %)
5 diff
(98.7 %id)
AW238021 normal squamous epithelium from retromolartrigone .g 2640 to 2995 368 to 10       359/368
(97 %)
0 diff
(100 %id)
F36574 pectoral muscle (after mastectomy) .g 2645 to 2905 1 to 264       264/264
(100 %)
10 diff
(96.3 %id)
BF759893 colon .g 2659 to 2932 1 to 273       273/273
(100 %)
9 diff
(96.8 %id)
AJ708640 heart .g 2660 to 2991 342 to 11   AAA Submitted on the opposite strand 332/332
(100 %)
0 diff
(100 %id)
N86713   .g 2660 to 2945 1 to 285       285/287
(99 %)
12 diff
(95.9 %id)
AW297569   .g 2663 to 2991 350 to 18   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 333/333
(100 %)
2 diff
(99.4 %id)
AV729396 hypothalamus .g 2674 to 2998 1 to 329   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 329/329
(100 %)
2 diff
(99.4 %id)
AW370370 breast .g 2688 to 2990 302 to 1       302/302
(100 %)
5 diff
(98.4 %id)
AW950528   .g 2691 to 2991 1 to 301   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 301/301
(100 %)
9 diff
(97.1 %id)
D29107   .g 2698 to 2991 1 to 295       295/295
(100 %)
1 diff
(99.7 %id)
T28375 colon, epididymis .g 2701 to 2991 1 to 290       290/290
(100 %)
2 diff
(99.4 %id)
AA834924   .g 2702 to 2999 300 to 3       298/300
(99 %)
0 diff
(100 %id)
W61313 heart .g 2707 to 2998 298 to 1   fully sequenced,   298/298
(100 %)
2 diff
(99.4 %id)
Z35498 leukemia .g 2719 to 2968 1 to 254       254/254
(100 %)
6 diff
(97.7 %id)
AW007975 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .g 2727 to 2998 272 to 1       272/272
(100 %)
2 diff
(99.3 %id)
AW151859 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .g 2727 to 2970 244 to 1       244/244
(100 %)
16 diff
(93.5 %id)
D25620   .g 2737 to 2921 1 to 188     Submitted on the opposite strand 188/188
(100 %)
4 diff
(97.9 %id)
AL121014 melanoma (MeWo cell line) .g 2748 to 2991 1 to 244   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 244/244
(100 %)
0 diff
(100 %id)
AI860702 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 2751 to 2999 251 to 3       249/251
(99 %)
0 diff
(100 %id)
BF529525 anaplastic oligodendroglioma with 1p/19qloss, brain .g 2765 to 2997 1 to 232   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 232/232
(100 %)
4 diff
(98.3 %id)
AA094349   .g 2771 to 2993 1 to 221       221/221
(100 %)
9 diff
(96.0 %id)
AW250773 lung, small cell carcinoma .g 2778 to 3000 233 to 11   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 223/223
(100 %)
1 diff
(99.6 %id)
CA448256 Chondrosarcoma, Left Pubic Bone .g 2812 to 2991 196 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 178/181
(98 %)
3 diff
(98.4 %id)
EC506106 Prostate .g 2852 to 2941 3 to 91       89/93
(95 %)
2 diff
(97.9 %id)
EC444853 Prostate .g 2896 to 2996 108 to 8       101/108
(93 %)
0 diff
(100 %id)
EC488777 Prostate .g 2896 to 2996 107 to 8       100/107
(93 %)
0 diff
(100 %id)
CN276491 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 2903 to 2998 1 to 96   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 96/96
(100 %)
2 diff
(98.0 %id)
T50115 ovary .g 2906 to 2965 62 to 1   fully sequenced,   62/62
(100 %)
0 diff
(100 %id)
GD144065   .g 2914 to 2998 1 to 85   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 85/85
(100 %)
3 diff
(96.5 %id)
GD158121   .g 2914 to 2991 1 to 79   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 79/79
(100 %)
3 diff
(96.3 %id)
BF761498 colon_est .h 1 to 223 25 to 246   tiling clone,   222/246
(90 %)
7 diff
(97.2 %id)
CV336983 placenta_normal .h 77 to 487 409 to 1   tiling clone, Submitted on the opposite strand 409/409
(100 %)
5 diff
(98.8 %id)
BE670386 carcinoid, lung .h 397 to 1034 638 to 1       638/642
(99 %)
10 diff
(98.5 %id)
BE219543 carcinoid, lung .h 444 to 1034 591 to 1       591/594
(99 %)
10 diff
(98.4 %id)
AV759516 bone marrow .h 444 to 889 9 to 451   tiling clone,   443/454
(97 %)
9 diff
(98.1 %id)
AW137475   .h 539 to 1031 510 to 18   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 493/493
(100 %)
1 diff
(99.8 %id)
CB114697 Liver .h 566 to 1048 484 to 4   tiling clone, Submitted on the opposite strand 481/484
(99 %)
0 diff
(100 %id)
AA922772 pooled germ cell tumors .h 567 to 1031 463 to 1       463/463
(100 %)
7 diff
(98.5 %id)
BF108650 carcinoid, lung .h 582 to 1034 453 to 1       453/453
(100 %)
1 diff
(99.8 %id)
AA974304 pooled germ cell tumors .h 585 to 1031 445 to 1       445/445
(100 %)
5 diff
(98.9 %id)
TI_153988407   .h 640 to 1031 483 to 92   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 392/392
(100 %)
0 diff
(100 %id)
AW204679   .h 660 to 1031 389 to 18   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 372/372
(100 %)
0 diff
(100 %id)
AW204532   .h 780 to 1037 261 to 4       258/261
(98 %)
0 diff
(100 %id)
AL707197 human skeletal muscle .h 782 to 1382 1 to 602   tiling clone,   602/602
(100 %)
3 diff
(99.6 %id)
AA887542 carcinoid, lung .h 963 to 1354 1 to 391   tiling clone, Submitted on the opposite strand 391/391
(100 %)
3 diff
(99.3 %id)
H61112 liver and spleen .h 992 to 1307 1 to 317       317/317
(100 %)
9 diff
(97.2 %id)
DA867161 Prostate .h 1589 to 2123 2 to 536   tiling clone, capped   535/535
(100 %)
3 diff
(99.5 %id)
BE501411 Kidney .h 1605 to 2164 561 to 1       561/561
(100 %)
4 diff
(99.3 %id)
H61113 liver and spleen .h 1724 to 2162 454 to 4   tiling clone,   451/456
(98 %)
0 diff
(100 %id)
AI023743 liver and spleen .h 1774 to 2164 391 to 1   tiling clone,   391/391
(100 %)
4 diff
(99.0 %id)
AL049064 testis .i 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
0 diff
(100 %id)
BM008348 Spleen .j 1 to 651 1 to 654 H149M P151R K152R K153Q M154* tiling clone,   654/815
(80 %)
13 diff
(98.5 %id)
TI_59383079   .j 2 to 651 132 to 784 H149M P151R K152R K153Q M154*     653/814
(80 %)
12 diff
(98.6 %id)
BQ706047 Spleen .j 3 to 910 1 to 914       914/915
(99 %)
30 diff
(96.8 %id)
BQ706364 Spleen .j 3 to 874 1 to 884       884/922
(95 %)
25 diff
(97.3 %id)
BM822304 stomach .j 123 to 638 1 to 516       516/516
(100 %)
3 diff
(99.5 %id)
CN301634 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 135 to 729 1 to 595   tiling clone,   595/595
(100 %)
1 diff
(99.9 %id)
CB159459 Liver .j 139 to 729 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BM804055 duodenal adenocarcinoma, cell line, small intestine .j 143 to 627 1 to 487       487/1097
(44 %)
5 diff
(99.6 %id)
BM792780 Ascites, stomach .j 144 to 575 1 to 432       432/432
(100 %)
1 diff
(99.8 %id)
R52257 breast .j 165 to 446 1 to 282       282/282
(100 %)
5 diff
(98.3 %id)
AI816110 brain, frontal lobe .j 193 to 639 1 to 447       447/447
(100 %)
0 diff
(100 %id)
AW161134 brain, frontal lobe .j 193 to 593 1 to 401       401/401
(100 %)
0 diff
(100 %id)
AW163574 brain, frontal lobe .j 193 to 660 1 to 468       468/468
(100 %)
0 diff
(100 %id)
BE899232 adenocarcinoma cell line, ovary .j 205 to 1003 1 to 799       799/1053
(75 %)
30 diff
(97.2 %id)
AI816150 brain, frontal lobe .j 683 to 1249 570 to 4   tiling clone,   567/570
(99 %)
0 diff
(100 %id)
AW161741 brain, frontal lobe .j 771 to 1249 482 to 4   tiling clone,   479/482
(99 %)
0 diff
(100 %id)
AW162857 brain, frontal lobe .j 772 to 1249 480 to 4       477/480
(99 %)
0 diff
(100 %id)
R52258 breast .j 884 to 1245 362 to 1       362/362
(100 %)
4 diff
(98.9 %id)
BI831144 brain, medulla .k 1 to 717 1 to 715   tiling clone,   715/717
(99 %)
5 diff
(99.4 %id)
TI_57177008   .k 1 to 717 68 to 782       715/784
(91 %)
8 diff
(99.0 %id)
BQ680026 melanotic melanoma, cell line, skin .k 460 to 768 1 to 309   tiling clone,   309/309
(100 %)
0 diff
(100 %id)
DW417033 Liver .k 574 to 872 9 to 307   tiling clone,   299/307
(97 %)
8 diff
(97.4 %id)
CV319496 nervous_tumor .l 1 to 328 1 to 335   tiling clone,   335/335
(100 %)
26 diff
(92.3 %id)
BM803202 duodenal adenocarcinoma, cell line, small intestine .l 67 to 633 1 to 567   tiling clone,   567/1138
(49 %)
14 diff
(98.8 %id)
BG002387 placenta_normal .l 389 to 906 8 to 523   tiling clone,   516/524
(98 %)
6 diff
(98.9 %id)
AF090912 Liver .l 421 to 2015 1 to 1599   tiling clone,   1599/1599
(100 %)
6 diff
(99.7 %id)
AI110830 Liver .l 421 to 943 1 to 524       524/524
(100 %)
4 diff
(99.3 %id)
AF075329 Liver .l 421 to 943 1 to 524       524/524
(100 %)
4 diff
(99.3 %id)
BE089508 breast .l 542 to 795 415 to 162     Submitted on the opposite strand 254/415
(61 %)
0 diff
(100 %id)
BI055568 placenta_normal .l 612 to 1113 530 to 1       530/532
(99 %)
0 diff
(100 %id)
CV360122 placenta_normal .l 1024 to 1592 31 to 598       568/598
(94 %)
6 diff
(99.0 %id)
DN994706 brain, whole brain .l 1170 to 1843 8 to 681   tiling clone,   674/681
(98 %)
6 diff
(99.2 %id)
BI037360 nervous_tumor .l 1205 to 1608 17 to 425       409/425
(96 %)
6 diff
(98.6 %id)
AI620815 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .l 1618 to 2134 1 to 517 F65X V80X A161D tiling clone, Submitted on the opposite strand 517/517
(100 %)
4 diff
(99.3 %id)
BF883732 lung_tumor .m 1 to 443 1 to 443 Y47F tiling clone,   443/443
(100 %)
1 diff
(99.8 %id)
BF883786 lung_tumor .m 1 to 443 1 to 443 Y47F     443/443
(100 %)
1 diff
(99.8 %id)
AI083678 B-cell, chronic lymphotic leukemia .n-u 1 to 477 477 to 1 E2G tiling clone,   477/477
(100 %)
1 diff
(99.8 %id)
CN301627 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 1 to 740 1 to 740 P2A tiling clone,   740/740
(100 %)
5 diff
(99.4 %id)
CN301626 embryonic stem cells, cell lines H1, H7, andH9 .o 566 to 1028 1 to 463   tiling clone,   463/463
(100 %)
0 diff
(100 %id)
AA835053   .p 1 to 323 323 to 1 R40Q tiling clone,   323/323
(100 %)
1 diff
(99.7 %id)
BQ710069 Spleen .q 1 to 708 1 to 712   tiling clone,   712/888
(80 %)
26 diff
(97.1 %id)
BU196047 melanotic melanoma, cell line, skin .q 53 to 788 1 to 743   tiling clone,   743/874
(85 %)
12 diff
(98.7 %id)
BQ878318 melanotic melanoma, cell line, skin .q 53 to 743 1 to 695       695/808
(86 %)
9 diff
(98.9 %id)
BU157711 melanotic melanoma, cell line, skin .q 53 to 660 1 to 608       608/912
(66 %)
35 diff
(96.2 %id)
BU191429 melanotic melanoma, cell line, skin .q 53 to 633 1 to 584       584/965
(60 %)
12 diff
(98.8 %id)
BU157616 melanotic melanoma, cell line, skin .q 53 to 741 1 to 693       693/960
(72 %)
17 diff
(98.3 %id)
BQ680660 melanotic melanoma, cell line, skin .q 53 to 702 1 to 653       653/926
(70 %)
17 diff
(98.2 %id)
BQ680706 melanotic melanoma, cell line, skin .q 53 to 731 1 to 684       684/925
(73 %)
36 diff
(96.2 %id)
BQ684243 melanotic melanoma, cell line, skin .q 53 to 662 1 to 611       611/905
(67 %)
22 diff
(97.6 %id)
BQ680981 melanotic melanoma, cell line, skin .q 53 to 497 1 to 445       445/998
(44 %)
12 diff
(98.8 %id)
BU839151 melanotic melanoma, cell line, skin .q 53 to 853 1 to 812       812/901
(90 %)
37 diff
(95.9 %id)
BQ684590 melanotic melanoma, cell line, skin .q 53 to 630 1 to 579       579/973
(59 %)
16 diff
(98.4 %id)
BQ677143 melanotic melanoma, cell line, skin .q 53 to 722 1 to 671       671/996
(67 %)
4 diff
(99.6 %id)
BQ676127 melanotic melanoma, cell line, skin .q 53 to 787 1 to 738       738/998
(73 %)
14 diff
(98.6 %id)
BQ680606 melanotic melanoma, cell line, skin .q 56 to 866 4 to 831       828/948
(87 %)
54 diff
(94.4 %id)
BF912945 uterus_tumor .q 423 to 723 1 to 300       300/300
(100 %)
8 diff
(97.4 %id)
BF914235 uterus_tumor .q 423 to 723 1 to 299       299/299
(100 %)
12 diff
(96.0 %id)
BG997766 head_neck .q 520 to 647 145 to 16       130/155
(83 %)
0 diff
(100 %id)
BQ433592 epithelioid carcinoma, Pancreas .q 686 to 1548 1 to 873 exact tiling clone,   873/892
(97 %)
20 diff
(97.8 %id)
BQ051679 blood, natural killer cells, cell line .q 802 to 1667 1 to 876 exact tiling clone,   876/952
(92 %)
20 diff
(97.9 %id)
DA578134   .r 1 to 543 2 to 544   tiling clone, capped   543/544
(99 %)
2 diff
(99.7 %id)
BI160837 epithelioid carcinoma cell line, Pancreas .r 470 to 933 19 to 489   tiling clone,   471/586
(80 %)
17 diff
(97.1 %id)
AW903462 nervous_normal .r 670 to 1092 2 to 419   tiling clone,   418/434
(96 %)
14 diff
(96.8 %id)
DA785427 brain .r 949 to 1408 2 to 460   tiling clone, capped   459/459
(100 %)
3 diff
(99.4 %id)
BG722651 testis .r 953 to 1539 1 to 591       591/591
(100 %)
20 diff
(96.7 %id)
BI560856 testis .r 953 to 1623 1 to 668   tiling clone,   668/668
(100 %)
12 diff
(98.3 %id)
TI_44349092   .r 957 to 1623 90 to 753       664/753
(88 %)
6 diff
(99.3 %id)
DB163754 thymus .r 1083 to 1631 2 to 551   tiling clone, capped   550/550
(100 %)
2 diff
(99.7 %id)
BE674493 carcinoid, lung .s 1 to 494 1 to 494 exact tiling clone, Submitted on the opposite strand 494/494
(100 %)
2 diff
(99.6 %id)
BE671537 carcinoid, lung .s 1 to 542 1 to 542 exact   Submitted on the opposite strand 542/542
(100 %)
2 diff
(99.7 %id)
BF110187 carcinoid, lung .s 1 to 485 1 to 485 H41R L46F P48F   Submitted on the opposite strand 485/485
(100 %)
8 diff
(98.4 %id)
BE218317 carcinoid, lung .s 2 to 442 1 to 441 H41R L46F P48F   Submitted on the opposite strand 441/441
(100 %)
7 diff
(98.5 %id)
BG054616 Kidney .s 2 to 524 1 to 523 G21S E34K G37S E38K   Submitted on the opposite strand 523/523
(100 %)
23 diff
(95.7 %id)
BE218787 carcinoid, lung .s 20 to 466 1 to 450 L46F   Submitted on the opposite strand 450/450
(100 %)
24 diff
(94.7 %id)
BE504503 carcinoid, lung .s 28 to 471 1 to 443 T27A L46F P48F F50L   Submitted on the opposite strand 443/444
(99 %)
18 diff
(96.0 %id)
BF591641 carcinoid, lung .s 43 to 553 1 to 512 exact   Submitted on the opposite strand 512/512
(100 %)
2 diff
(99.7 %id)
BF432897 carcinoid, lung .s 50 to 574 1 to 525 exact   Submitted on the opposite strand 525/525
(100 %)
5 diff
(99.1 %id)
BE671670 carcinoid, lung .s 52 to 493 1 to 441 C11W V12G H41R L46F P48F   Submitted on the opposite strand 441/441
(100 %)
10 diff
(97.8 %id)
CA950824 Pancreas, Purified pancreatic islet .s 335 to 646 1 to 312   tiling clone, Submitted on the opposite strand 312/475
(65 %)
5 diff
(99.0 %id)
BP431811   .s 642 to 1037 1 to 396   tiling clone,   396/396
(100 %)
7 diff
(98.3 %id)
BE857704 Prostate .s 834 to 1364 531 to 1       531/531
(100 %)
4 diff
(99.3 %id)
BI962987.
matches multiple genes
Islets of Langerhans, Pancreas .s 838 to 1370 1 to 533   tiling clone, also hits gene PCM1 533/534
(99 %)
3 diff
(99.5 %id)
BI963969 Islets of Langerhans, Pancreas .s 838 to 1370 1 to 534       534/540
(98 %)
4 diff
(99.3 %id)
AI199111 anaplastic oligodendroglioma, brain .s 908 to 1366 459 to 1       459/461
(99 %)
1 diff
(99.8 %id)
AI492070 B-cell, chronic lymphotic leukemia .s 908 to 1355 448 to 1       448/450
(99 %)
1 diff
(99.8 %id)
AI417414 anaplastic oligodendroglioma, brain .s 908 to 1366 459 to 1       459/461
(99 %)
1 diff
(99.8 %id)
AI420495 Prostate .s 929 to 1367 439 to 1       439/439
(100 %)
2 diff
(99.6 %id)
AW137380   .s 995 to 1366 387 to 16   tiling clone, AAA   372/372
(100 %)
0 diff
(100 %id)
H06994 whole brain .t 1 to 602 1 to 609   tiling clone,   609/612
(99 %)
31 diff
(95.0 %id)
BI028477 marrow .t 157 to 523 1 to 366   tiling clone,   366/366
(100 %)
4 diff
(99.0 %id)
BY993905   .t 465 to 1151 1 to 687 exact tiling clone,   687/687
(100 %)
2 diff
(99.8 %id)
DB145859 thymus .u-u 1 to 543 2 to 546 exact tiling clone, capped   545/545
(100 %)
2 diff
(99.7 %id)
BG699062 brain, hippocampus .u-u 204 to 987 1 to 782 exact tiling clone,   782/782
(100 %)
16 diff
(98.0 %id)
AW878438 ovary .u-u 348 to 616 1 to 269       269/269
(100 %)
3 diff
(98.9 %id)
BG977477 colon_ins .va-u 1 to 410 410 to 1 exact tiling clone,   410/410
(100 %)
1 diff
(99.8 %id)
AW027473 pooled germ cell tumors .va-u 263 to 765 515 to 11   tiling clone, AAA   505/505
(100 %)
10 diff
(98.1 %id)
BI001149 head_normal .va-u 377 to 492 129 to 14       116/129
(89 %)
0 diff
(100 %id)
DA770435 brain .vb 1 to 572 2 to 573 T40A R51H tiling clone, capped   572/572
(100 %)
3 diff
(99.5 %id)
DB482451 hippocampus .vb 4 to 498 1 to 495 T40A R51H     495/495
(100 %)
3 diff
(99.4 %id)
BM713125 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vb 52 to 274 1 to 223   tiling clone,   223/223
(100 %)
1 diff
(99.6 %id)
BX952490   .vc-u 1 to 566 1 to 567 exact tiling clone,   567/567
(100 %)
1 diff
(99.9 %id)
BQ372396 prostate_normal .vd-u 1 to 251 252 to 2 exact tiling clone,   251/254
(98 %)
10 diff
(96.1 %id)
BQ332944 lung_tumor .ve-u 1 to 305 309 to 11 E21K tiling clone,   299/309
(96 %)
0 diff
(100 %id)
BF849391 lung_normal Gene SPG7, variant not shown         Submitted on the opposite strand    
83 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o, .p, .q, .r, .s, .t, .u-u, .va-u, .vb, .vc-u, .vd-u, .ve-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI